company
THERAKOS DEVELOPMENT LIMITED
Jurisdiction: US
FDA Warning Letter timeline
V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.
- fda_recall · device_recall2026-04-22THERAKOS DEVELOPMENT LIMITED — Class II recall: Brand Name: Cellex Photopheresis System Product Name: CELLEX Photopheresis Kit…
Frequently asked questions
- How many FDA warning letters has THERAKOS DEVELOPMENT LIMITED received?
- Argus HQ has not recorded an FDA warning letter for THERAKOS DEVELOPMENT LIMITED in our current dataset.
- What FDA recalls has THERAKOS DEVELOPMENT LIMITED issued?
- Argus HQ has recorded 1 FDA recall tied to THERAKOS DEVELOPMENT LIMITED.
- Is THERAKOS DEVELOPMENT LIMITED FDA compliant?
- Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 1 recall, and 0 approval records for THERAKOS DEVELOPMENT LIMITED. Review the linked FDA source records directly before drawing a compliance conclusion.
Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.

